CNMD Stock Overview
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
CONMED Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$70.01 |
| 52 Week High | US$138.47 |
| 52 Week Low | US$69.78 |
| Beta | 1.34 |
| 1 Month Change | -8.67% |
| 3 Month Change | -25.35% |
| 1 Year Change | -38.65% |
| 3 Year Change | -48.69% |
| 5 Year Change | -12.22% |
| Change since IPO | 3,400.50% |
Recent News & Updates
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Apr 18
Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28Recent updates
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Apr 18Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%
Feb 15US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results
Feb 03Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?
Jan 08Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects
Dec 18CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt
Nov 30Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business
Oct 28Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?
Sep 22Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Aug 24Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly
Jul 28Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?
Jun 08These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively
May 17Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Apr 28Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Mar 10Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden
Feb 14CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M
Feb 02Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Jan 24ConMed: Still Fairly Priced, Turning More Constructive
Dec 09At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?
Nov 18Conmed withdraws FY22 guidance on software implementation-related disruption
Nov 15CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet
Oct 11ConMed: Fairly Priced At Pre-Pandemic Market Cap
Sep 21CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20
Sep 03CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20
Aug 18CONMED declares $0.20 dividend
Aug 11Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?
Jul 20We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt
Jun 23Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today
Jun 10Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)
May 25Shareholder Returns
| CNMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -3.8% | 1.8% | 1.2% |
| 1Y | -38.6% | -0.5% | 24.9% |
Return vs Industry: CNMD underperformed the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: CNMD underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| CNMD volatility | |
|---|---|
| CNMD Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CNMD's share price has been volatile over the past 3 months.
Volatility Over Time: CNMD's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 4,000 | Curt Hartman | www.conmed.com |
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.
CONMED Corporation Fundamentals Summary
| CNMD fundamental statistics | |
|---|---|
| Market cap | US$2.20b |
| Earnings (TTM) | US$64.46m |
| Revenue (TTM) | US$1.24b |
33.4x
P/E Ratio1.7x
P/S RatioIs CNMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNMD income statement (TTM) | |
|---|---|
| Revenue | US$1.24b |
| Cost of Revenue | US$559.90m |
| Gross Profit | US$684.85m |
| Other Expenses | US$620.39m |
| Earnings | US$64.46m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.09 |
| Gross Margin | 55.02% |
| Net Profit Margin | 5.18% |
| Debt/Equity Ratio | 116.5% |
How did CNMD perform over the long term?
See historical performance and comparison